Testing effectiveness (Phase 2)Study completedNCT00003356What this trial is testingRituximab Plus Interleukin-2 in Treating Patients With LymphomaWho this might be right forLymphoma University of Rochester 58
Testing effectiveness (Phase 2)UnknownNCT03185494What this trial is testingTreatment of Relapsed and/or Chemotherapy Refractory B-cell Malignancy by Tandem CAR T Cells Targeting CD19 and CD22Who this might be right forHematopoietic/Lymphoid CancerAdult Acute Lymphoblastic Leukemia in RemissionB-cell Adult Acute Lymphoblastic Leukemia+20 more Chinese PLA General Hospital 30
Early research (Phase 1)Study completedNCT00621452What this trial is testingGenetically Engineered Lymphocytes, Cyclophosphamide, and Aldesleukin in Treating Patients With Relapsed or Refractory Mantle Cell Lymphoma or Indolent B-Cell Non-Hodgkin LymphomaWho this might be right forB-cell Chronic Lymphocytic LeukemiaExtranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid TissueNodal Marginal Zone B-cell Lymphoma+8 more Fred Hutchinson Cancer Center 12
Early research (Phase 1)WithdrawnNCT00004114What this trial is testingChemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Advanced Hematologic CancerWho this might be right forLeukemiaLymphomaMyelodysplastic Syndromes Jonsson Comprehensive Cancer Center
Early research (Phase 1)Study completedNCT00004904What this trial is testingStem Cell Transplantation in Treating Patients With Hematologic CancerWho this might be right forChronic Myeloproliferative DisordersGraft Versus Host DiseaseLeukemia+5 more Northwestern University
Testing effectiveness (Phase 2)Study completedNCT00086944What this trial is testingOblimersen, Rituximab and Combination Chemotherapy in Treating Patients With Relapsed or Refractory Aggressive Non-Hodgkin's LymphomaWho this might be right forRecurrent Adult Diffuse Large Cell LymphomaRecurrent Grade 3 Follicular LymphomaRecurrent Mantle Cell Lymphoma National Cancer Institute (NCI) 25
Testing effectiveness (Phase 2)Study completedNCT01314014What this trial is testingImexon for Relapsed Follicular and Aggressive LymphomasWho this might be right forFollicular LymphomaSmall Lymphocytic LymphomaMarginal Zone Lymphoma+4 more University of Rochester 22
Early research (Phase 1)Study completedNCT00002759What this trial is testingIrinotecan Plus Cyclosporine and Phenobarbital in Treating Patients With Solid Tumors or LymphomaWho this might be right forDrug/Agent Toxicity by Tissue/OrganLymphomaNeutropenia+2 more National Cancer Institute (NCI) 3
Testing effectiveness (Phase 2)Study completedNCT02278796What this trial is testingA Trial Comparing the Two High-dose Chemotherapies BeEAM and BEAM Given Before Autologous Stem Cell Transplantation (ASCT) in Lymphoma Patients (BEB-trial)Who this might be right forLymphoma, Large B-Cell, DiffuseLymphoma, FollicularLymphoma, Mantle-Cell Insel Gruppe AG, University Hospital Bern 108
Early research (Phase 1)WithdrawnNCT04995536What this trial is testingCpG-STAT3 siRNA CAS3/SS3 and Localized Radiation Therapy for the Treatment of Relapsed/Refractory B-Cell NHLWho this might be right forRecurrent B-Cell Non-Hodgkin LymphomaRecurrent Diffuse Large B-Cell LymphomaRecurrent Grade 1 Follicular Lymphoma+17 more City of Hope Medical Center
Testing effectiveness (Phase 2)Ended earlyNCT00288067What this trial is testingFenretinide and Rituximab in Treating Patients With B-Cell Non-Hodgkin LymphomaWho this might be right forAdult Nodular Lymphocyte Predominant Hodgkin LymphomaB-cell Chronic Lymphocytic LeukemiaContiguous Stage II Adult Burkitt Lymphoma+57 more National Cancer Institute (NCI) 32
Testing effectiveness (Phase 2)Study completedNCT00003406What this trial is testingCombination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Refractory CancerWho this might be right forChronic Myeloproliferative DisordersLeukemiaLymphoma+4 more Cancer Treatment Centers of America 30
Not applicableLooking for participantsNCT03452774What this trial is testingSYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and RegistryWho this might be right forCancer, MetastaticCancerCancer of Pancreas+40 more Massive Bio, Inc. 50,000
Early research (Phase 1)Study completedNCT00880815What this trial is testingFludarabine, Bendamustine, and Rituximab in Treating Participants With Lymphoid Cancers Undergoing Stem Cell TransplantWho this might be right forCD20 PositiveChronic Lymphocytic LeukemiaFollicular Lymphoma+4 more M.D. Anderson Cancer Center 60
Early research (Phase 1)Study completedNCT00890747What this trial is testingSunitinib Malate in Treating HIV-Positive Patients With Cancer Receiving Antiretroviral TherapyWho this might be right forAccelerated Phase Chronic Myelogenous LeukemiaAcute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic SyndromeAcute Undifferentiated Leukemia+82 more National Cancer Institute (NCI) 42
Testing effectiveness (Phase 2)Looking for participantsNCT04195633What this trial is testingDonor Stem Cell Transplant With Treosulfan, Fludarabine, and Total-Body Irradiation for the Treatment of Hematological MalignanciesWho this might be right forAcute LeukemiaAcute Lymphoblastic LeukemiaAcute Myeloid Leukemia+16 more Fred Hutchinson Cancer Center 60
Early research (Phase 1)Study completedNCT01129193What this trial is testingAR-42 in Treating Patients With Advanced or Relapsed Multiple Myeloma, Chronic Lymphocytic Leukemia, or LymphomaWho this might be right forAdult Nasal Type Extranodal NK/T-cell LymphomaAnaplastic Large Cell LymphomaAngioimmunoblastic T-cell Lymphoma+64 more Amir Mortazavi 44
Testing effectiveness (Phase 2)Study completedNCT00387959What this trial is testingChemotherapy, Radiation Therapy, Rituximab, and Umbilical Cord Blood Transplant in Treating Patients With B-Cell Non-Hodgkin's LymphomaWho this might be right forLeukemiaLymphoma Memorial Sloan Kettering Cancer Center 17
Not applicableEnded earlyNCT00900068What this trial is testingBlood Samples From Patients on a Clinical Trial to CINV During HSCTWho this might be right forBreast CancerChronic Myeloproliferative DisordersGestational Trophoblastic Tumor+9 more OHSU Knight Cancer Institute 9
Not applicableNo Longer AvailableNCT00423826What this trial is testingUmbilical Cord Blood Stem Cell Transplant in Treating Patients With Hematologic Cancer or Other DiseaseWho this might be right forLeukemiaLymphomaMultiple Myeloma and Plasma Cell Neoplasm+3 more Barbara Ann Karmanos Cancer Institute